Compounds useful as inhibitors of ATR kinase

Details for Australian Patent Application No. 2009313198 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Charrier, Jean-damien; Durrant, Steven; Kay, David; O'Donnell, Michael; Knegtel, Ronald; Maccormick, Somhairle; Pinder, Joanne; Virani, Anisa; Young, Stephen; Binch, Hayley; Cleveland, Thomas; Fanning, Lev T.d.; Hurley, Dennis; Joshi, Pramod; Sheth, Urvi; Silina, Alina; Reaper, Philip Michael

Agent Baldwins

Pub. Number AU-A-2009313198

PCT Pub. Number WO2010/054398

Priority 61/112,906 10.11.08 US; 61/163,655 26.03.09 US; 61/114,204 13.11.08 US; 61/146,463 22.01.09 US

Filing date 10 November 2009

Wipo publication date 14 May 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054398 Priority application(s): WO2010/054398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313201-Novel lipids and compositions for the delivery of therapeutics

2009313197-N-cadherin: target for cancer diagnosis and therapy